XL184; BMS-907351
849217-68-1
501.5
C28H24FN3O5
DMF, DMSO, Ethanol
-20°C
Cabozantinib is a cell-permeable, potent inhibitor of MET, vascular endothelial growth factor receptor 2 (VEGFR2), and RET, with robust antiangiogenic, antitumor, and anti-invasive effects.
0.1 lbs
Substance Name:BSA fraction V
CAS Number:9048-46-8
Substance Name:NSC 79534; sodium vanadium oxide
CAS Number:13721-39-6
Substance Name:(3β)-3-[2-(Diethylamino)ethoxy]androst-5-en-17-one, hydrochloride
CAS Number:3039-71-2
Substance Name:(11α,13E,15S)-11,15-Dihydroxy-9-oxo-prost-13-en-1-oic acid; Alprostadil; PGE1
CAS Number:745-65-3
Substance Name:N-[2-(2-Pyridinyl)-6-(1,2,4,5-tetrahydro-3H-3-benzazepin-3-yl)-4-pyrimidinyl]-β-alanine, ethyl ester
CAS Number:1373423-53-0
Substance Name:(3β)-3-[2-(Diethylamino)ethoxy]androst-5-en-17-one, hydrochloride
CAS Number:3039-71-2
Substance Name:(11α,13E,15S)-11,15-Dihydroxy-9-oxo-prost-13-en-1-oic acid; Alprostadil; PGE1
CAS Number:745-65-3
Substance Name:N-[[(1,2,3,5,6,7-Hexahydro-s-indacen-4-yl)amino]carbonyl]-4-(1-hydroxy-1-methylethyl)-2-furansulfonamide sodium salt; CRID3; CP-456773 sodium salt
CAS Number:256373-96-3
Substance Name:(1E,3E)-1-(4-Fluorophenyl)-2-methylpent-1-en-3-one oxime
CAS Number:1170613-55-4